CCL2 and metabolic syndrome: In the broader context of chronic diseases, dyslipidemia promotes the recruitment of inflammatory cells, such as macrophages, to affected tissues, where they release pro-inflammatory cytokines and chemokines, including TNF-α, IL-1β, IL-6, IL-8, MCP-1, VEGF, and adhesion molecules [52,150,151].